AI Search Summary
This video discusses a study where psilocin extended lifespan in human cells and psilocybin-treated elderly mice survived at higher rates than control mice. It emphasizes that the findings are promising but animal and cell results do not directly prove human longevity benefits, and human dosing intervals are uncertain.
- Main question: Can psilocybin mushrooms increase human longevity?
- Short answer / core takeaway: The study results are intriguing in cells and mice, but the video treats human longevity claims as unproven and calls for better trials.
- Evidence type: Science-news explainer about cell, mouse, human-trial dose comparison, and weak observational human data.
- Search topics: psilocybin longevity, psilocin cells lifespan, psilocybin mice aging, telomeres, oxidative stress, psychedelic observational data.
Common Search Questions
Did psilocybin increase lifespan in the study?
The video says psilocin extended human-cell lifespan in vitro, and elderly mice given psilocybin once per month had higher survival than control mice by the 28-month mark.
Does this mean mushrooms extend human lifespan?
No direct human longevity conclusion is established in the video. The creator notes that applying the effect to humans is uncertain and that human longevity studies are difficult.
How often would the mouse dosing translate to humans?
The video gives two different translations: roughly once per 8 to 14 weeks based on drug metabolism speed, or once every three years based on species-invariant biological time.
Key Takeaways
- Psilocybin is broken down into psilocin, the psychedelic molecule discussed in the cell work.
- Low-concentration psilocin reportedly extended human-cell lifespan by 29%.
- A ten-times higher dose reportedly boosted cell lifespan by 57%.
- The video says psilocin lowered oxidative stress and lengthened telomeres in the study.
- Elderly mice given monthly psilocybin for 10 months had higher survival than controls by the 28-month mark.
- The creator cautions that the mouse result does not directly prove human longevity benefits.
- The workbook had a blank caption for this video.
Transcript
Opening claim and caution
I just might have to try shrooms for science. I applaud his dedication to science.
He showed a study where shrooms increased longevity. But to apply that study’s effect to yourself, you need to have one particular physical trait.
Let’s dive in.
Psilocybin and psilocin
Shrooms contain psilocybin, which gets broken down into psilocin, which is the actual psychedelic molecule.
Applying a low concentration of psilocin to human cells extended their lifespan by 29%.
Ten times that dose boosted it up to 57%. It lowered oxidative stress and lengthened telomeres.
Elderly mouse study
So next they decided to give some elderly mice an interesting time.
They took 19-month-old mice, roughly the equivalent of 60 to 65 human years, and gave them psilocybin once per month for 10 months.
By the 28-month-old mark, around 92 human years, half of the control mice were dead, but 80% of the psilocybin mice were still alive.
And they were showing subjective improvements in overall fur quality, including hair and reductions in white hair compared to vehicle-treated mice.
What this means for humans
So this is pretty fantastic news if you have whiskers. And maybe those are next on the list for Immortal Unk.
But what does it mean for us humans?
The research said that the dose they used for the mice was based off the dose used in this human trial. I checked and it was 25 milligrams of psilocybin, which is roughly the equivalent of 2.5 grams of dried mushrooms, although those tend to vary a lot based on the specifics of the batch.
Translating mouse timing to human timing
But what would once per mouse month translate to with humans?
There are two common ways of calculating. Based on drug metabolism speed, it will be roughly once per 8 to 14 weeks in humans.
But based on relative lifespans, called species-invariant biological time, it would be once every three years.
Quite a difference.
Human evidence is still weak
Unfortunately, running longevity studies on humans is really hard.
But we do have some weak observational data linking psychedelic use to lowered rates of heart attacks, cancer, and depression, as well as some brain function improvement in the elderly.
So I’m excited to see some better trials. I’ll keep you updated.
Additional Notes
The workbook caption field was blank for this video.
References
- Psilocin/psilocybin longevity study in cells and elderly mice discussed in transcript; title/source URL/DOI/PMID not listed in workbook.
- Human psilocybin trial and observational psychedelic-health data mentioned in transcript; direct source details not listed in workbook.